Literature DB >> 12706106

Transcriptional gene expression profile of human esophageal squamous cell carcinoma.

Rinu Sharma1, Sharmishtha Samantaray, Nootan Kumar Shukla, Ranju Ralhan.   

Abstract

To identify the genes involved in esophageal carcinogenesis, we compared gene expression profiles in esophageal squamous cell carcinoma (ESCC) and matched normal esophageal epithelial tissues. Differential display analysis revealed significant changes in the expression of 26 genes; 21 genes were upregulated and 5 genes were downregulated. The differentially expressed genes included those associated with cellular metabolism, cell structure, transcription, proliferation, apoptosis, signal transduction, complement pathway, and cell-cell adhesion. The differential expression of these genes was confirmed by reverse Northern blot analysis. Reverse transcription PCR analysis of ESCC and matched normal esophageal tissues provided the first evidence that melanoma metastasis clone D (MEMD), a gene similar to oncostatin M receptor beta, and KIAA0471 gene products are upregulated in ESCCs. Intriguingly, KIAA0471, a novel gene product, is upregulated in esophageal tumors showing nodal invasion. Identification of these differentially expressed genes in esophageal tumors adds to the repertoire of genes associated with esophageal carcinogenesis and they may thus serve as potential novel molecular targets for diagnosis and therapy. Further characterization of known and unknown differentially expressed cDNAs identified in this study may provide significant clues for understanding the molecular mechanisms underlying esophageal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706106     DOI: 10.1016/s0888-7543(03)00023-5

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  RABGAP1L gene rearrangement resulting from a der(Y)t(Y;1)(q12;q25) in acute myeloid leukemia arising in a child with Klinefelter syndrome.

Authors:  Maria Cristina Roberti; Roberta La Starza; Cecilia Surace; Pietro Sirleto; Rita Maria Pinto; Valentina Pierini; Barbara Crescenzi; Cristina Mecucci; Adriano Angioni
Journal:  Virchows Arch       Date:  2009-01-28       Impact factor: 4.064

Review 2.  14-3-3ζ as a prognostic marker and therapeutic target for cancer.

Authors:  Christopher L Neal; Dihua Yu
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

3.  Protein and mRNA characterization in high and low metastasis adenoid cystic carcinoma cell lines.

Authors:  Jie-lin Yang; Nai-shuo Zhu; Ying Wang; Xiao-feng Guan; Zhao-xin Zheng
Journal:  Mol Biol Rep       Date:  2004-12       Impact factor: 2.316

4.  Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.

Authors:  Nobuyuki Watanabe; Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Takuma Ohashi; Wataru Okajima; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Hitoshi Tsuda; Eigo Otsuji
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

5.  Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.

Authors:  Tasneem Kausar; Rinu Sharma; Md Raghibul Hasan; Anoop Saraya; Tushar K Chattopadhyay; Siddartha Datta Gupta; Ranju Ralhan
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

6.  Construction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.

Authors:  Li Liang; Yan-Qing Ding; Xin Li; Guang-Zhi Yang; Jun Xiao; Li-Chun Lu; Jin-Hua Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

7.  Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.

Authors:  Y Nishimura; S Komatsu; D Ichikawa; H Nagata; S Hirajima; H Takeshita; T Kawaguchi; T Arita; H Konishi; K Kashimoto; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; E Otsuji
Journal:  Br J Cancer       Date:  2013-02-19       Impact factor: 7.640

8.  Over-expression of 14-3-3zeta is an early event in oral cancer.

Authors:  Ajay Matta; Sudhir Bahadur; Ritu Duggal; Siddhartha D Gupta; Ranju Ralhan
Journal:  BMC Cancer       Date:  2007-09-02       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.